Humacyte, Inc. - *W EXP 08/27/202 (HUMAW) Institutional Ownership

13F Institutional Holders and Ownership History from Q3 2021 to Q3 2025

Type / Class
Equity / *W EXP 08/27/202
Symbol
HUMAW on Nasdaq
Price per share
$0.14
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares
429,978
Total reported value
$113,278
% of total 13F portfolios
0%
Share change
+537
Value change
-$2,216
Number of holders
6
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

As of 30 Sep 2025, 6 institutional investors reported holding 429,978 shares of Humacyte, Inc. - *W EXP 08/27/202 (HUMAW).

Institutional Holders of Humacyte, Inc. - *W EXP 08/27/202 (HUMAW) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q3 429,978 $113,278 -$2,216 $0.27 6
2025 Q2 429,441 $167,934 +$2,142 $0.40 6
2025 Q1 424,584 $156,721 -$24,194 $0.37 5
2024 Q4 442,498 $806,283 -$164,472 $1.82 5
2024 Q3 533,939 $958,009 -$590,059 $1.80 8
2024 Q2 900,997 $1,260,554 +$410,639 $1.39 11
2024 Q1 638,738 $384,268 -$22,696 $0.60 8
2023 Q4 799,708 $333,447 -$35,689 $0.42 11
2023 Q3 866,272 $573,337 -$23,025 $0.72 9
2023 Q2 912,816 $659,654 +$246,053 $0.73 10
2023 Q1 635,813 $377 -$90 $0.00 10
2022 Q4 874,854 $339 +$7 $0.00 11
2022 Q3 721,848 $808 -$171,017 $0.00 11
2022 Q2 916,189 $810,000 +$318,019 $0.88 11
2022 Q1 $1.95 2
2021 Q4 $2.28 2
2021 Q3 528,391 $1,544,000 +$1,543,993 $2.90 14